Download Files:
Etravirine-d8
SKU
HY-132508S-1 mg
Category Isotope-Labeled Compounds
Tags Anti-infection;Others, HIV;Isotope-Labeled Compounds;Reverse Transcriptase, Infection
Products Details
Product Description
– Etravirine-d8 is the deuterium labeled Etravirine. Etravirine (R165335) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV[1][2].
Web ID
– HY-132508S
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C20H9D6BrN6O
References
– [1]Andries, K., et al. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Antimicrob Agents Chemother, 2004. 48(12): p. 468|[2]Lazzarin, A., et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet, 2007. 370(9581): p. 39-48.|[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
CAS Number
– 1142096-06-7
Molecular Weight
– 443.33
SMILES
– O(C1=NC(NC2=CC=C(C#N)C=C2)=NC(N)=C1Br)C3=C(C([2H])([2H])[2H])C=C(C#N)C=C3C([2H])([2H])[2H]
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HIV;Isotope-Labeled Compounds;Reverse Transcriptase
Pathway
– Anti-infection;Others
Product type
– Isotope-Labeled Compounds
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.